Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 4,758 | 5,111 | 4,973 | 4,404 | 3,102 |
| Cost of Goods | 2,919 | 2,920 | 2,704 | 2,548 | 1,866 |
| Gross Profit | 1,839 | 2,191 | 2,268 | 1,855 | 1,237 |
| Operating Expenses | 3,371 | 3,154 | 3,122 | 2,927 | 3,404 |
| Operating Income | -613 | -43 | -150 | -524 | -1,302 |
| Interest Expense | 69 | 70 | 36 | 0 | 0 |
| Other Income | 2 | -6 | 1 | -1 | 4 |
| Pre-tax Income | -680 | -119 | -185 | -525 | -1,298 |
| Income Tax | N/A | 80 | -1 | N/A | -4 |
| Net Income Continuous | -680 | -198 | -184 | -525 | -1,294 |
| Net Income | $-680 | $-190 | $-186 | $-525 | $-1,302 |
| EPS Basic Total Ops | -0.02 | -0.01 | -0.01 | -0.02 | -0.04 |
| EPS Basic Continuous Ops | -0.02 | 0.00 | -0.01 | -0.01 | -0.04 |
| EPS Diluted Total Ops | -0.02 | -0.01 | -0.01 | -0.02 | -0.04 |
| EPS Diluted Continuous Ops | -0.02 | 0.00 | -0.01 | -0.01 | -0.04 |
| EBITDA(a) | $24 | $606 | $451 | $-21 | $-935 |